mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000

View company profile
Current Jobs

Healthcare Partnership Manager
Location: North East

UCB appoints new executive vice-president

Posted on 11/11/2009 in Pharmaceutical Company Restructures

UCB, a pharmaceutical firm, has announced the recruitment of a new executive vice-president within its ranks.

Ismail Kola will take up the posts of executive vice-president of UCB and the president of new medicines and will join the company's executive committee from November 23rd 2009.

Mr Kola's previous position was that of senior vice-president of discovery, research and early clinical research and experimental medicine and chief scientific officer at Schering-Plough.

Before this, the professional occupied the role of senior vice-president and site head of basic research at Merck.

"UCB is gaining a highly accomplished scientist with a track record of success in academia and the biopharma field. I am confident that Ismail will make major leaps to the development of UCB NewMedicines," explained Roch Doliveux, chief executive officer of the firm.

Last month, UCB posted its financial results for the third quarter of 2009, revealing the strong growth of Xyzal (levocetirizine) in the US and of Zyrtec (cetirizine) in Japan.

Other news stories from 11/11/2009

Read more in the Zenopa News Archive

How this news is generated

Nikki
Account Manager
for this opportunity

01494 818032
(Mon to Fri 0830 to 1800 hours)
nikki@zenopa.com

Latest News

UCB signs 1.5bn euro revolving credit facility

UCB completes placement of senior unsecured bonds

UCB announces changes to UK site operations

UCB appoints new executive vice-president

UCB announces its latest financial results

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use